Clinical Trials Browser

Interventional × Psoriasis × Clear all

NCT03816345 2026-04-13

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

Arthritis, Rheumatoid, Autoimmune Diseases, Colitis, Ulcerative, Crohn Disease, Dermatomyositis, Lupus Erythematosus, Systemic, Multiple Sclerosis, Psoriasis, Scleroderma, Systemic, Sjogren's Syndrome, Inflammatory Bowel Diseases, Arthritis, Psoriatic, Hematologic Neoplasms

NCT07289399 2025-12-17

Is There a Benefit From Addition of Treadmill Walking to Diet Restriction in Psoriasis Women With PCOS?

Phase NA Recruiting

40 enrolled

Polycystic Ovary Syndrome, Psoriasis

NCT01351805 2025-12-03

VITAL

Phase NA Completed

25,871 enrolled 15 charts

Arthritis, Rheumatoid, Autoimmune Diseases, Osteoarthritis, Psoriasis

NCT06281106 2025-04-02

TYPP

Phase 2/3 Terminated

2 enrolled

Psoriasis

Clinical Trials

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

Is There a Benefit From Addition of Treadmill Walking to Diet Restriction in Psoriasis Women With PCOS?

VITAL

TYPP

ADVANCE

Study of Tumor Necrosis Factor Receptor Fusion Protein Etanercept (Enbrel) in Psoriasis of the Hands and/or Feet

Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune Disease

A Study to Evaluate the Efficacy and Safety of Secukinumab in Adult Patients With Skin Types IV-VI With Moderate to Severe Plaque Psoriasis

Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial)

CALYPSO

A Dose Finding Study of AEB071 Assessing Psoriasis Area and Severity Index in Patients With Plaque Psoriasis

A Phase 2b Study of Baricitinib in Participants With Moderate to Severe Psoriasis

A Study in Participants With Moderate to Severe Psoriasis

Taclonex Ointment With Hydrogel Patch Occlusion for the Treatment of Psoriasis

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Asian Subjects With Moderate To Severe Plaque Psoriasis

SIGNATURE

Study to Evaluate Safety and Efficacy of Oral MP1032 in Psoriasis Patients

Evaluate Safety and Tolerability of Calcipotriene Foam 0.005% in Pediatric Subjects With Mild/Moderate Plaque Psoriasis

A Study To Evaluate The Effects And Safety Of Treatment, Treatment Withdrawal, Followed By Re-Treatment With CP-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis

A Phase 3, Multi Site, Randomized, Double Blind, Placebo Controlled Study Of The Efficacy And Safety Comparing CP- 690,550 And Etanercept In Subjects With Moderate To Severe Chronic Plaque Psoriasis

Safety and Efficacy of UC-MSCs in Patients With Plaque Psoriasis

CLEAR

Can We Miss Pigmented Lesions in Psoriasis Patients?

BioUV2017

MOA

A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis

REFINE

Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis

Tofacitinib Ointment For Chronic Plaque Psoriasis

A Long Term Study To Evaluate The Safety, Tolerability And Efficacy Of CP-690,550 In Patients With Moderate To Severe Plaque Psoriasis And/Or Psoriatic Arthritis

Ultraviolet (UVA and UVB) Light Therapy in the Treatment of Inflammatory Skin Conditions

A One-Year Study To Evaluate The Effects And Safety Of CP-690,550 In Patients With Moderate To Severe Chronic Plaque Psoriasis

A One-Year Study To Evaluate The Efficacy And Safety Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis

Exploratory Study of Natural Killer Cells in Human Skin

Evaluating the Safety of Etanercept 50 mg Twice Weekly in Subjects With Psoriasis

Evaluating the Safety of Etanercept in the Treatment of Psoriasis in Adult Subjects

OnderHUIDs